Court ruling on bluebird bio’s gene therapy marketing campaign ‘sparks’ dismay at Roche’s Spark
Court ruling on bluebird bio’s gene therapy marketing campaign ‘sparks’ [...]
Court ruling on bluebird bio’s gene therapy marketing campaign ‘sparks’ [...]
BioNTech preps hiring spree at mRNA vaccine plant, boosting workforce [...]
Johnson & Johnson CEO: Consumer health split won’t interfere with [...]
Deciphera details stomach cancer flop against Pfizer’s Sutent, cracking the [...]
Samsung Biologics outlines mRNA ambitions as “Super Plant” speeds toward [...]
Gilead pulls 2 cancer accelerated approvals as changing lymphoma landscape [...]
On second thought, Oncopeptides decides not to give up on [...]
Pfizer takes a surprising hit to its rare disease plan [...]
Poland’s largest pharma scouts for joint bidder in potential $4B [...]
Fierce JPM Week: Bristol Myers’ next-gen autoimmune med not just another [...]